Add BrightSurf on Google Email

iPS cells from dish to freezer and back

Researchers at Kobe University developed a method to preserve iPS cells directly in their culture dishes using D-proline as a cryoprotectant. This allows for easy automation of the process, reducing costs and increasing efficiency in regenerative medicine and drug discovery research. The breakthrough enables the direct freezing, thawin...

SourceKobe University·JournalBiochemical Engineering Journal·TypeExperimental study·DateDec 18, 2025

New paper-based device boosts HIV test accuracy from dried blood samples

Researchers at Tufts University have developed a paper-based device that accurately measures HIV viral loads from dried blood samples, outperforming industry standards. The device, called the plasma spot card, was tested on 75 South African patients and showed improved accuracy in detecting drug-resistant mutations.

SourceTufts University·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateFeb 24, 2025

Life’s building blocks in Bennu samples

The OSIRIS-REx mission returned a large sample from asteroid Bennu, which Japanese collaborators detected includes all five nucleobases required for life. The analysis revealed high concentrations of ammonia and nitrogen-rich organic matter.

SourceHokkaido University·JournalNature Astronomy·TypeExperimental study·DateJan 29, 2025

Guideline on handling endobronchial ultrasound transbronchial needle samples released by CHEST

The American College of Chest Physicians has released a new clinical guideline on endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) specimen processing and handling to standardize the process. The guidelines aim to improve diagnostic yield and specimen preservation for downstream ancillary testing.

SourceAmerican College of Chest Physicians·JournalCHEST Journal·DateOct 1, 2024

Handheld diagnostic lab offers point-of-care solution for future pandemics

A handheld diagnostic lab developed by UCLA researchers can fully automate pooled testing and detect multiple diseases, reducing costs and usage of scarce supplies. The technology can be easily manufactured, deployed, and performed at a doctor's office or mass testing sites, helping authorities prepare for future pandemics.

SourceUniversity of California - Los Angeles·JournalNature·TypeExperimental study·DateNov 10, 2022